Literature DB >> 22808960

Clinical practice. Benign prostatic hyperplasia and lower urinary tract symptoms.

Aruna V Sarma1, John T Wei.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22808960     DOI： 10.1056/NEJMcp1106637

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  44 in total

Review 1.  Short-, Intermediate-, and Long-term Quality of Life Outcomes Following Radical Prostatectomy for Clinically Localized Prostate Cancer.

Authors:  Vinay Prabhu; Ted Lee; Tyler R McClintock; Herbert Lepor
Journal:  Rev Urol       Date:  2013

2.  Cranberry fruit powder (Flowens™) improves lower urinary tract symptoms in men: a double-blind, randomized, placebo-controlled study.

Authors:  Ales Vidlar; Vladimir Student; Jitka Vostalova; Emilie Fromentin; Marc Roller; Vilím Simanek; Vladimir Student
Journal:  World J Urol       Date:  2015-06-07       Impact factor: 4.226

Review 3.  Lower Urinary Tract Symptoms Following Transurethral Resection of Prostate.

Authors:  Soo Jeong Kim; Omar Al Hussein Alawamlh; Bilal Chughtai; Richard K Lee
Journal:  Curr Urol Rep       Date:  2018-08-20       Impact factor: 3.092

Review 4.  Self-report measurement of lower urinary tract symptoms: a commentary on the literature since 2011.

Authors:  James W Griffith
Journal:  Curr Urol Rep       Date:  2012-12       Impact factor: 3.092

5.  Association of benign prostatic hyperplasia and subsequent risk of bladder cancer: an Asian population cohort study.

Authors:  Chu-Wen Fang; Cheng-Hsi Liao; Shih-Chi Wu; Chih-Hsin Muo
Journal:  World J Urol       Date:  2018-02-09       Impact factor: 4.226

6.  Radical prostatectomy improves and prevents age dependent progression of lower urinary tract symptoms.

Authors:  Vinay Prabhu; Glen B Taksler; Ganesh Sivarajan; Juliana Laze; Danil V Makarov; Herbert Lepor
Journal:  J Urol       Date:  2013-08-13       Impact factor: 7.450

7.  The change of IPSS 7 (nocturia) score has the maximum influence on the change of Qol score in patients with lower urinary tract symptoms.

Authors:  Woo Suk Choi; Hwancheol Son
Journal:  World J Urol       Date:  2018-08-02       Impact factor: 4.226

8.  Anoctamin 1 (TMEM16A) is essential for testosterone-induced prostate hyperplasia.

Authors:  Joo Young Cha; Jungwon Wee; Jooyoung Jung; Yongwoo Jang; Byeongjun Lee; Gyu-Sang Hong; Beom Chul Chang; Yoon-La Choi; Young Kee Shin; Hye-Young Min; Ho-Young Lee; Tae-Young Na; Mi-Ock Lee; Uhtaek Oh
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-07       Impact factor: 11.205

9.  Medical management of benign prostatic hyperplasia: Results from a population-based study.

Authors:  Mohamed Bishr; Katharina Boehm; Vincent Trudeau; Zhe Tian; Paolo Dell'Oglio; Jonas Schiffmann; Claudio Jeldres; Maxine Sun; Sharokh F Shariat; Markus Graefen; Fred Saad; Pierre I Karakiewicz
Journal:  Can Urol Assoc J       Date:  2016 Jan-Feb       Impact factor: 1.862

10.  Specific deletion of LKB1/Stk11 in the Müllerian duct mesenchyme drives hyperplasia of the periurethral stroma and tumorigenesis in male mice.

Authors:  Jitu W George; Amanda L Patterson; Pradeep S Tanwar; André Kajdacsy-Balla; Gail S Prins; Jose M Teixeira
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-13       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.